This page is part of the FHIR Specification (v4.1.0: Release 4B Ballot #1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions
. Page versions: R5 R4B R4 R3
| Pharmacy Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Encounter, Patient, Practitioner |
Raw JSON (canonical form + also see JSON Format Specification)
Request for Intravenous Chemotherapy (inpatient order) - Brentuximab Vedotin - completed
{
"resourceType": "MedicationRequest",
"id": "medrx0316",
"text": {
"status": "generated",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><p><b>identifier</b>: id: 12345689 (OFFICIAL)</p><p><b>status</b>: completed</p><p><b>intent</b>: order</p><p><b>medication</b>: <a> </a></p><blockquote><p><b>code</b>: <span>Adcetris</span></p><p><b>form</b>: <span>Lyophilized powder for injectable solution (qualifier value) </span></p><h3>Batches</h3><table><tr><td>-</td><td><b>LotNumber</b></td><td><b>ExpirationDate</b></td></tr><tr><td>*</td><td>12345</td><td>2019-10-31</td></tr></table></blockquote><p><b>subject</b>: <a>Donald Duck. Generated Summary: Medical record number: 654321 (USUAL); active; Duck Donald (OFFICIAL); gender: male</a></p><p><b>encounter</b>: <a>encounter who leads to this prescription. Generated Summary: id: v1451 (OFFICIAL); status: finished; <span>ambulatory</span>; <span>Patient-initiated encounter</span>; <span>Non-urgent cardiological admission</span>; <span>Heart valve replacement</span></a></p><p><b>authoredOn</b>: 2015-01-15</p><p><b>requester</b>: <a>Patrick Pump. Generated Summary: id: 874635264 (OFFICIAL), id: 567IUI51C154 (USUAL); Simone Heps (OFFICIAL); Phone: 020556936, S.M.Heps@bmc.nl, Fax: 0205669283; gender: female; birthDate: 1971-11-07</a></p><p><b>instantiatesUri</b>: <a>http://www.bccancer.bc.ca/chemotherapy-protocols-site/Documents/Lymphoma-Myeloma/ULYBRENTUX%20Protocol_1Jun2017.pdf</a></p><h3>DosageInstructions</h3><table><tr><td>-</td></tr><tr><td>*</td></tr></table></div>"
},
"contained": [
{
"resourceType": "Medication",
"id": "med0306",
"code": {
"coding": [
{
"system": "http://hl7.org/fhir/sid/ndc",
"code": "51144-050-01",
"display": "Adcetris"
}
]
},
"form": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "421637006",
"display": "Lyophilized powder for injectable solution (qualifier value) "
}
]
},
"batch": {
"lotNumber": "12345",
"expirationDate": "2019-10-31"
}
}
],
"identifier": [
{
"use": "official",
"system": "http://www.bmc.nl/portal/prescriptions",
"value": "12345689"
}
],
"status": "completed",
"intent": "order",
"medicationReference": {
"reference": "#med0306"
},
"subject": {
"reference": "Patient/pat1",
"display": "Donald Duck"
},
"encounter": {
"reference": "Encounter/f001",
"display": "encounter who leads to this prescription"
},
"authoredOn": "2015-01-15",
"requester": {
"reference": "Practitioner/f007",
"display": "Patrick Pump"
},
"instantiatesUri": [
"http://www.bccancer.bc.ca/chemotherapy-protocols-site/Documents/Lymphoma-Myeloma/ULYBRENTUX%20Protocol_1Jun2017.pdf"
],
"dosageInstruction": [
{
"sequence": 1,
"text": "1.8 mg/kg IV infusion over 20 minutes every 3 weeks for 16 cycles",
"timing": {
"repeat": {
"count": 16,
"frequency": 1,
"period": 3,
"periodUnit": "wk"
}
},
"route": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "255560000",
"display": "Intravenous"
}
]
},
"doseAndRate": [
{
"type": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/dose-rate-type",
"code": "ordered",
"display": "Ordered"
}
]
},
"doseQuantity": {
"value": 1.8,
"unit": "mg/kg",
"system": "http://unitsofmeasure.org",
"code": "mg/kg"
},
"rateRatio": {
"numerator": {
"value": 1.8,
"system": "http://unitsofmeasure.org",
"code": "mg/kg"
},
"denominator": {
"value": 20,
"system": "http://unitsofmeasure.org",
"code": "min"
}
}
}
],
"maxDosePerLifetime": {
"value": 400,
"unit": "mg",
"system": "http://unitsofmeasure.org",
"code": "mg"
}
}
]
}
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.